CHUNG OWYANG
Pharmacy in Ann Arbor, MI
License number
Michigan 4301040549
Expiration Date
Jan 31, 2019
Category
Pharmacy
Type
CS - 3
Address
Address
Ann Arbor, MI 48109
Personal information
See more information about CHUNG OWYANG at radaris.comName
Address
Phone
3600 Fox Hunt Dr, Ann Arbor, MI 48105
3600 Fox Hunt Dr, Ann Arbor, MI 48105
Organization information
See more information about CHUNG OWYANG at bizstanding.comChung Owyang MD
1500 E Medical Ctr Dr, Ann Arbor, MI 48109
Industry:
Gastroenterology, Internist
Phone:
(734) 647-5944 (Phone)
Chung D. Owyang
Professional information
Chung Owyang, Ann Arbor MI
Specialties:
Gastroenterologist
Address:
1150 W Medical Center Dr, Ann Arbor, MI 48109
1500 E Medical Center Dr, Ann Arbor, MI 48109
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
McGill University, Faculty of Medicine - Doctor of Medicine
The Mayo Clinic - Fellowship - Gastroenterology (Internal Medicine)
The Mayo Clinic - Fellowship - Gastroenterology (Internal Medicine)
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Gastroenterology (Internal Medicine)
Dr. Chung Owyang, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Gastroenterology
Address:
1500 E Medical Center Dr, Ann Arbor 48109
(734) 647-5944 (Phone)
University Of Michigan GAS
1500 E Medical Center Dr SUITE 3912, Ann Arbor 48109
(734) 647-5944 (Phone)
(734) 647-5944 (Phone)
University Of Michigan GAS
1500 E Medical Center Dr SUITE 3912, Ann Arbor 48109
(734) 647-5944 (Phone)
Certifications:
Gastroenterology, 1981, Internal Medicine, 1976
Awards:
Healthgrades Honor Roll
Languages:
English, Chinese
Hospitals:
1500 E Medical Center Dr, Ann Arbor 48109
University Of Michigan GAS
1500 E Medical Center Dr SUITE 3912, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
University Of Michigan GAS
1500 E Medical Center Dr SUITE 3912, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
McGill University Faculty Of Medicine
Graduated: 1972
Montreal Genl Hospital McGill University
Graduated: 1973
Graduated: 1975
Mayo Grad School
Graduated: 1978
McGill University Faculty Of Medicine
Graduated: 1972
Montreal Genl Hospital McGill University
Graduated: 1973
Graduated: 1975
Mayo Grad School
Graduated: 1978
Chung Owyang, Ann Arbor MI
Work:
Univ. of Michigan Health System
1500 E Medical Center Dr, Ann Arbor, MI 48109
1500 E Medical Center Dr, Ann Arbor, MI 48109
Orphanin Fq Receptor Nucleic Acids
US Patent:
6849449, Feb 1, 2005
Filed:
Mar 1, 2002
Appl. No.:
10/087345
Inventors:
Chung Owyang - Ann Arbor MI, US
Assignee:
Regents of the University of Michigan - Ann Arbor MI
International Classification:
C12N 1585, C12N 500, A01K 67027, C07H 2104
US Classification:
435325, 4353201, 4352523, 800 8, 536 235
Abstract:
The present invention provides Orphanin FQ receptor nucleic acid sequences. Specifically, the present invention provides nucleic acid sequences of differentially expressed splice variants of the Orphanin FQ receptor. The present invention also provides methods of using the Orphanin FQ receptor nucleic acid sequences for the identification of pharmaceutical agents and the generation of animal models of Orphanin FQ receptor-mediated disease states. The present invention thus provides improved method of screening potential therapeutics useful in the treatment of a variety of disease states mediated by Orphanin FQ signaling.
Methods Of Treating Intestinal Disorders
US Patent:
5929035, Jul 27, 1999
Filed:
Apr 14, 1998
Appl. No.:
9/059845
Inventors:
Chung Owyang - Ann Arbor MI
Assignee:
Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 3800, A61K 3802, C07K 500, C07K 700
US Classification:
514 13
Abstract:
Methods and compositions are described for the treatment of intestinal disorders, and, more specifically, for improving motility in the colon in humans and animals. Compositions comprising neuropeptides are administered to humans and animals having symptoms of post-operative ileus.
Orphanin Fq Receptor
US Patent:
7173010, Feb 6, 2007
Filed:
May 19, 2004
Appl. No.:
10/848637
Inventors:
Chung Owyang - Ann Arbor MI, US
Assignee:
Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 38/04, A61K 38/00
US Classification:
514 13, 530300, 530326
Abstract:
The present invention provides Orphanin FQ receptor nucleic acids and polypeptides and uses thereof. In particular, the present invention provides nucleic acid sequences of differentially expressed splice variants of the Orphanin FQ receptor. The present invention also provides methods of using the Orphanin FQ receptor nucleic acid sequences and ligands for the identification of pharmaceutical agents, the generation of animal models of Orphanin FQ receptor-mediated disease states, and for formulating biological activities. The present invention further provides improved methods of screening potential therapeutics useful in the treatment of a variety of disease states mediated by Orphanin FQ signaling, as well as therapeutics identified using the screening methods.
Orphanin Fq Receptor Polypeptides
US Patent:
7112658, Sep 26, 2006
Filed:
Dec 14, 2004
Appl. No.:
11/011450
Inventors:
Chung Owyang - Ann Arbor MI, US
Assignee:
Regents of the University of Michigan - Ann Arbor MI
International Classification:
C07K 14/72, C07K 14/575
US Classification:
530350, 530399
Abstract:
The present invention provides Orphanin FQ receptor nucleic acid sequences. Specifically, the present invention provides nucleic acid sequences of differentially expressed splice variants of the Orphanin FQ receptor. The present invention also provides methods of using the Orphanin FQ receptor nucleic acid sequences for the identification of pharmaceutical agents and the generation of animal models of Orphanin FQ receptor-mediated disease states. The present invention thus provides improved method of screening potential therapeutics useful in the treatment of a variety of disease states mediated by Orphanin FQ signaling.